Back

Inflammatory targets in atherosclerosis.

27 August 2021 (09:41 - 09:52)
Organised by:
Congress Presentation Part of: What's next to reduce cardiovascular risk? Risk Factors and Prevention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
LDL lowering: does it matter how?
Professor J. Boren (Goteborg, SE)
Slides Video
Presentation thumbnail
Triglycerides: the underestimated player.
Professor E. Stroes (Amsterdam, NL)
Slides Video
Presentation thumbnail
What's next to reduce cardiovascular risk? – discussion.
Presentation thumbnail
What's next to reduce cardiovascular risk? - Chat Moderator.

Access the full session

Session thumbnail
What's next to reduce cardiovascular risk?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 09:41 CET
You may be interested in
thumbnail
Webinar
Inflammation in cardiovascular disease and classification of human atherosclerotic plaques according to underlying biology and clinical presentation
10 September 2024
thumbnail
Congress Presentation
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis
27 August 2021
thumbnail
Congress Presentation
Association of inflammatory markers and ultrasonographic indicators of endothelial (dys)function in humans
12 April 2024
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources